• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于静脉内给予胰岛素和胰高血糖素的新型脉冲调制闭环人工胰腺。

A novel pulse-modulated closed-loop artificial pancreas based on intravenous administration of insulin and glucagon.

机构信息

, Lochem, The Netherlands.

Fontys University of Applied Sciences, Eindhoven, The Netherlands.

出版信息

Sci Rep. 2024 Nov 4;14(1):26659. doi: 10.1038/s41598-024-77800-0.

DOI:10.1038/s41598-024-77800-0
PMID:39496716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535037/
Abstract

Current attempts to implement and apply automated control systems for the management of glucose homeostasis in individuals with diabetes are partly successful. In most semi and closed loop control systems to mimic the action of a normal pancreas in diabetes patients, insulin is administered subcutaneously. However, the parameters for insulin diffusion and transport time constants are relatively large and have wide individual variations. Therefore, deviation from a normal meal can result in suboptimal euglycemic control. Stable and reliable closed loop feedback control using continuous glucose monitoring under these conditions is difficult and needs regular interventions from the user. This article describes the translation of the endocrine physiology of a normal pancreas to an electronic equivalent. With this translation, the complex effects of a direct intravenous pulsatile method of insulin and glucagon administration can be simulated in accordance with physiological observations in a healthy subject and has been built with standard electronic components. This device is applicable for any individual and under any condition to automatically maintain the desired optimal euglycemic condition. The insulin and glucagon response control is presented in the same physiological pulsatile manner as is observed in healthy individuals.

摘要

目前,在糖尿病患者中实施和应用自动化控制系统来管理血糖稳态的尝试取得了一定的成功。在大多数半闭环和闭环控制系统中,为了模拟正常胰腺在糖尿病患者中的作用,胰岛素是通过皮下注射给药的。然而,胰岛素扩散和传输时间常数的参数相对较大,并且具有广泛的个体差异。因此,偏离正常饮食可能导致血糖控制不佳。在这些情况下,使用连续血糖监测进行稳定可靠的闭环反馈控制是困难的,需要用户定期进行干预。本文描述了将正常胰腺的内分泌生理学转化为电子等效物。通过这种转换,可以根据健康受试者的生理观察来模拟直接静脉内脉冲式胰岛素和胰高血糖素给药的复杂效应,并且已经使用标准电子元件构建了该系统。该设备适用于任何个体和任何条件,可自动维持所需的最佳血糖稳态。胰岛素和胰高血糖素反应控制以与健康个体中观察到的相同生理脉冲方式呈现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/b474b3fc192a/41598_2024_77800_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/ef6ce2642fc5/41598_2024_77800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/84c8232898a0/41598_2024_77800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/fc31e102bd44/41598_2024_77800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/062c7d88c0b3/41598_2024_77800_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/d89bfe350aea/41598_2024_77800_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/5990b95f9c16/41598_2024_77800_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/b474b3fc192a/41598_2024_77800_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/ef6ce2642fc5/41598_2024_77800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/84c8232898a0/41598_2024_77800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/fc31e102bd44/41598_2024_77800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/062c7d88c0b3/41598_2024_77800_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/d89bfe350aea/41598_2024_77800_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/5990b95f9c16/41598_2024_77800_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a51/11535037/b474b3fc192a/41598_2024_77800_Fig7_HTML.jpg

相似文献

1
A novel pulse-modulated closed-loop artificial pancreas based on intravenous administration of insulin and glucagon.一种基于静脉内给予胰岛素和胰高血糖素的新型脉冲调制闭环人工胰腺。
Sci Rep. 2024 Nov 4;14(1):26659. doi: 10.1038/s41598-024-77800-0.
2
Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.一种具有胰岛素和胰高血糖素双泵输送功能的全自动闭环人工胰腺控制系统的研发。
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:397-400. doi: 10.1109/IEMBS.2011.6090127.
3
Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.双激素人工胰腺治疗 1 型糖尿病:最新进展与未来方向。
Artif Organs. 2021 Sep;45(9):968-986. doi: 10.1111/aor.14023. Epub 2021 Jul 15.
4
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.葡萄糖反应性胰岛素和胰高血糖素递送(双激素人工胰腺)在 1 型糖尿病成人中的随机交叉对照试验。
CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.
5
Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.使用自适应餐时大剂量计算器增强1型糖尿病的自动闭环血糖控制——日内变异性下的计算机模拟评估
Comput Methods Programs Biomed. 2017 Jul;146:125-131. doi: 10.1016/j.cmpb.2017.05.010. Epub 2017 Jun 1.
6
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较:一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
7
Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.使用液体稳定胰高血糖素制剂的双激素闭环系统与仅胰岛素闭环系统对比预测性低血糖暂停系统:一项开放标签、门诊、单中心、交叉、随机对照试验。
Diabetes Care. 2020 Nov;43(11):2721-2729. doi: 10.2337/dc19-2267. Epub 2020 Sep 9.
8
Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.自适应双激素、双传感器人工胰腺的自动控制及住院研究期间的评估
IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81. doi: 10.1109/TBME.2014.2323248. Epub 2014 May 13.
9
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.应用仿生胰腺与常规胰岛素泵治疗对青春期前 1 型糖尿病患儿的血糖昼夜控制:一项随机交叉试验。
Lancet Diabetes Endocrinol. 2016 Mar;4(3):233-243. doi: 10.1016/S2213-8587(15)00489-1. Epub 2016 Feb 3.
10
Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.闭环控制期间皮下微剂量胰高血糖素的疗效决定因素
J Diabetes Sci Technol. 2010 Nov 1;4(6):1288-304. doi: 10.1177/193229681000400602.

本文引用的文献

1
Assessment of Meal Anticipation for Improving Fully Automated Insulin Delivery in Adults With Type 1 Diabetes.评估进餐期待感,改善 1 型糖尿病成人患者的全自动化胰岛素输注
Diabetes Care. 2023 Sep 1;46(9):1652-1658. doi: 10.2337/dc23-0119.
2
Safety of immediate use of totally implantable venous access ports in adult patients with cancer: a retrospective single-center study.成年癌症患者立即使用完全植入式静脉输液港的安全性:一项回顾性单中心研究。
Korean J Clin Oncol. 2021 Dec;17(2):104-110. doi: 10.14216/kjco.21016. Epub 2021 Dec 31.
3
Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial.
成人 2 型糖尿病患者的全自动闭环胰岛素输注:一项开放标签、单中心、随机交叉试验。
Nat Med. 2023 Jan;29(1):203-208. doi: 10.1038/s41591-022-02144-z. Epub 2023 Jan 11.
4
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence.人工胰腺系统的最新进展:临床证据的综合评价。
Diabetes Metab J. 2021 Nov;45(6):813-839. doi: 10.4093/dmj.2021.0177. Epub 2021 Nov 22.
5
Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes.1型糖尿病患者腹腔内胰岛素吸收的建模
Metabolites. 2021 Sep 3;11(9):600. doi: 10.3390/metabo11090600.
6
An algorithm mimicking pancreas pulsatile behavior improves artificial pancreas performance.模拟胰腺脉动行为的算法可提高人工胰腺性能。
Int J Artif Organs. 2021 Oct;44(10):756-764. doi: 10.1177/03913988211027176. Epub 2021 Aug 4.
7
Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.双激素人工胰腺闭环控制在 1 型糖尿病成人患者中的应用:一项门诊、随机、交叉试验。
Diabetes Care. 2021 Mar;44(3):836-838. doi: 10.2337/dc20-2106. Epub 2021 Jan 4.
8
The Merging of Biological and Electronic Circuits.生物电路与电子电路的融合
iScience. 2020 Oct 15;23(11):101688. doi: 10.1016/j.isci.2020.101688. eCollection 2020 Nov 20.
9
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.随机 II 期试验评估在早期乳腺癌辅助化疗期间使用外周插入导管与植入式端口导管的安全性。
Eur J Cancer. 2020 Feb;126:116-124. doi: 10.1016/j.ejca.2019.11.022. Epub 2020 Jan 10.
10
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A and Hypoglycemia.每周调整胰岛素输注设置的12周全天动态人工胰腺:对糖化血红蛋白和低血糖的影响。
Diabetes Care. 2017 Dec;40(12):1719-1726. doi: 10.2337/dc17-1188. Epub 2017 Oct 13.